TDRL-551

• Description :

  TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 µM) with potential anticancer activity.TDRL-551 inhibits RPA-DNA interaction and enhances the efficacy of platinum-based chemotherapy for lung and ovarian cancer.

• CAS Number :

  1644626-43-6

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  591.83

• Molecular Formula :

  C25H23ClIN3O4

• Notes :

  Research use only, not for human use.

• Receptor :

  Others